Publication | Closed Access
SUSTAINED DRUG‐INDUCED ELEVATION OF BRAIN GABA IN THE RAT<sup>1</sup>
104
Citations
13
References
1973
Year
Aoaa InjectionsPharmacotherapyExperimental PharmacologySocial SciencesPre-clinical PharmacologyMolecular PharmacologyPharmacological StudyBrain Gaba LevelsToxicologyNeurologyNeurochemistryNeuropharmacologyNeuroprotectionPharmacologyInhibitory NeurotransmittersNeurophysiologyNeuroscienceCentral Nervous SystemMedicineDaily Injections
Abstract— The contents of GABA, homocarnosine, and β‐alanine can be raised in rat brain for long periods of time by the continued administration of phenelzine, aminooxyacetic acid (AOAA), or isonicotinic acid hydrazide (INH). These 3 compounds apparently act by preferential inhibition of the enzyme GABA aminotransferase (GABA‐T). Oral administration of phenelzine (20 mg/kg per day) caused a 25–50 per cent increase in GABA levels in rat brain, but produced appreciable toxic side effects. A similar increase in GABA levels in brain resulted from oral administration to rats of INH in a dosage of 60 mg/kg per day, without production of any obvious toxic effects. Simultaneous administration of large doses of pyridoxine did not abolish the GABA‐elevating effect of INH. Brain GABA levels in the rat were increased by approx. 50 per cent by daily injections of AOAA (2.5 mg/kg per day). At this low dosage, AOAA injections in rats could be continued for at least 6 weeks without producing evident toxic effects. Oral administration of large amounts of GABA, on the other hand, failed to increase the content of GABA in the brains of rats not treated with GABA‐T inhibitors, and failed to produce any further increase of brain GABA levels in rats treated with AOAA.
| Year | Citations | |
|---|---|---|
Page 1
Page 1